Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase.
about
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialTargeting soluble guanylate cyclase for the treatment of pulmonary hypertension.Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Modulation of cGMP in heart failure: a new therapeutic paradigm.Enantioselective synthesis of beta-(3-hydroxypyrazol-1-yl) ketones using an organocatalyzed Michael addition reactionA Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction.The chemistry and biology of soluble guanylate cyclase stimulators and activators.Efficient synthesis of 1,3-diaryl-4-halo-1H-pyrazoles from 3-arylsydnones and 2-aryl-1,1-dihalo-1-alkenes.Synthesis, spectral analysis and in vitro microbiological evaluation of novel ethyl 4-(naphthalen-2-yl)-2-oxo-6-arylcyclohex-3-enecarboxylates and 4,5-dihydro-6-(napthalen-2-yl)-4-aryl-2H-indazol-3-ols.Synthesis of 2,3-dihydro-1H-indazoles by Rh(III)-catalyzed C-H cleavage of arylhydrazines.Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
P2860
Q24656131-B7E592F2-5431-4E7A-B3EA-3EE6F8B3453BQ34179857-7CB1B01D-BCAD-4994-AC49-699B831D2D93Q35010064-9293B58E-4996-4F0B-B12B-363C3CE29CE2Q35075847-F9D3B7EA-5C69-4280-92EA-7D49B2D95C61Q37329891-9207D2D8-7DF2-47FC-B963-2D91171EAB67Q37363203-26C4128A-F10C-475D-84CC-0DDC873CC9BCQ37820206-6306B7FA-5722-45A0-912D-5BFE416DD3D2Q38130465-0E8EA003-D67B-4F04-9216-8F39909DCADCQ40214445-C22648FE-A811-46C1-90B7-AB61630C1EEEQ46846948-543ABABA-6E42-40C8-B9F4-9B2ED0F219F3Q53039769-39CF6903-5A10-4701-8E29-5FB3AC3D9FFAQ57300061-5F1829C8-75E9-4FC2-A611-06254CC04929
P2860
Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Synthesis and biological evalu ...... or, soluble guanylate cyclase.
@ast
Synthesis and biological evalu ...... or, soluble guanylate cyclase.
@en
type
label
Synthesis and biological evalu ...... or, soluble guanylate cyclase.
@ast
Synthesis and biological evalu ...... or, soluble guanylate cyclase.
@en
prefLabel
Synthesis and biological evalu ...... or, soluble guanylate cyclase.
@ast
Synthesis and biological evalu ...... or, soluble guanylate cyclase.
@en
P2093
P356
P1476
Synthesis and biological evalu ...... or, soluble guanylate cyclase.
@en
P2093
Brummell DG
Budworth J
Campbell RO
Charles IG
Fernandez PA
P356
10.1021/JM001034K
P407
P577
2001-01-01T00:00:00Z